An Interactive Mobile Care on Self-management Among T2DM with OSA
Launched by CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY · Jan 4, 2025
Trial Information
Current as of November 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people with Type 2 Diabetes Mellitus (T2DM) who also have Obstructive Sleep Apnea (OSA). The researchers want to see if using a mobile health platform called "My OSA Coach" can improve self-management of these conditions. Participants will be randomly divided into two groups: one group will use the mobile health tool for six months, while the other group will not receive this intervention.
To be eligible for this study, participants must be over 20 years old, have a confirmed diagnosis of Type 2 Diabetes, and have a body mass index (BMI) above 24 or a waist measurement that is larger than 90 cm for men or 80 cm for women. They must also have a specific level of sleep apnea confirmed by a sleep specialist. Participants should be comfortable using digital technology, as the study relies on mobile health tools. However, individuals with serious health issues like cancer or severe heart and lung diseases will not be able to participate. This trial is not yet recruiting, but it aims to help improve the lives of those dealing with both diabetes and sleep apnea.
Gender
ALL
Eligibility criteria
- Inclusion criteria :
- • Age over 20 years with a physician-confirmed diagnosis of Type 2 Diabetes Mellitus (T2DM)
- • BMI greater than 24 kg/m2, or waist circumference (WC) greater than 90cm for men or greater than 80 cm for women
- • AHI as evaluated by a home portable sleep monitor at \> 5 times/hour and diagnosed with sleep apnea by a specialist in sleep apnea
- • agreeing to participate in this 6-month study .current digital technology product users.
- Exclusion criteria:
- • presence of major diseases such as cancer , renal failure or severe depression
- • presence of cardiopulmonary diseases not suitable for physical activities
About Chang Gung University Of Science And Technology
Chang Gung University of Science and Technology is a leading academic institution in Taiwan dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to integrating science and technology in medical applications, the university actively sponsors clinical trials aimed at enhancing patient outcomes and exploring novel therapeutic interventions. With a multidisciplinary approach and a focus on collaboration, Chang Gung University of Science and Technology leverages its expertise to contribute significantly to the field of clinical research, ensuring adherence to the highest ethical standards and regulatory guidelines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miaoli, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported